MYXREDLIN, Insulin Human in 0.9% Sodium Chloride Injection, 100 units/100 mL (1 unit/mL),…
Official notice from a government agency or its published feed.
Reason: CGMP Deviations
Class IIA mid-level FDA recall: the product may cause temporary or reversible health problems. · Ongoing · US Nationwide; Puerto Rico; and Chile.
Hazard: CGMP Deviations
View the FDA enforcement report ↗ ← All reports